|
Zulvac BTV
|
-
|
EU/2/17/207/005
|
Zoetis Belgium S.A., Beļģija
|
QI04AA02
|
cattle; sheep
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Inactivated bluetongue virus, serotype 4, strain SPA-1/2004
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Zoetis Manufacturing Research Spain S L, Spānija
|
| Date of authorisation/renewal: |
26-Apr-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/17/207/005 |
|
1 |
Polietilēna pudele, 50 deva |
-
|
|
|
Porcilis ColiClos
|
-
|
EU/2/12/141/009
|
Intervet International B.V., Nīderlande
|
QI09AB08
|
pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
F4ab (K88ab) fimbrial adhesin,F5 (K99) fimbrial adhesin,F4ac (K88ac) fimbrial adhesin,Echerichia coli LT toxoid,F6 fimbrial adhesin of E. coli,Toxoid Clostridium perfringens, type C
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
14-Jun-2012
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/12/141/009 |
250 deva |
1 |
Stikla pudelīte, 250 deva |
-
|
|
|
Rheumocam
|
0.5 mg/ml
|
EU/2/07/078/023
|
Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
|
QM01AC06
|
cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for oral use
|
| International name (active substance): |
Meloxicam
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
18-Dec-2012
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/07/078/023 |
15 ml |
1 |
Flakons, 15 ml |
-
|
|
|
Lotilaner/Milbemycin Elanco 225 mg/8,44 mg
|
-
|
EU/2/26/361/009
|
Elanco GmbH, Vācija
|
QP54AB51
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Lotilaner, Milbemycin oxime
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Elanco France S.A.S, Francija
|
| Date of authorisation/renewal: |
25-Feb-2026
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/26/361/009 |
|
1 |
Al/Al blisteris, 1 tablete |
-
|
|
|
Cardalis
|
-
|
EU/2/12/142/003
|
Ceva Sante Animale, Francija
|
QC09BA07
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Spironolactone,Benazepril hydrochloride
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Ceva Sante Animale, Francija
|
| Date of authorisation/renewal: |
28-Aug-2012
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/12/142/003 |
5 mg/40 mg |
30 |
Pudelīte, 1 tablete |
-
|
|
|
Fluralaner Intervet
|
400 mg
|
EU/2/25/346/015
|
Intervet International B.V., Nīderlande
|
QP53BE02
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Fluralaner
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
27-Jun-2025
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/25/346/015 |
|
3 |
Blisteris, 1 tablete |
-
|
|
|
ERYSENG PARVO
|
-
|
EU/2/14/167/003
|
Laboratorios Hipra S.A., Spānija
|
QI09AL01
|
pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Inactivated Erysipelothrix rhusiopathiae ,Inactivated swine parvovirus strain
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Laboratorios Hipra S.A., Spānija
|
| Date of authorisation/renewal: |
05-Oct-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/14/167/003 |
|
1 |
Stikla flakons, 50 deva |
-
|
|
|
Evalon
|
-
|
EU/2/16/194/003
|
Laboratorios Hipra S.A., Spānija
|
QI01AN01
|
chickens
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension and solvent for oral spray
|
| International name (active substance): |
Oocysts of Eimeria necatrix, strain mednec 3+8,Oocysts of Eimeria brunetti, strain roybru 3+28,Eimeria acervulina (strain RA|3+20),Eimeria maxima (strain MCK+10),Eimeria tenella (strain Rt 3+15)
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Laboratorios Hipra S.A., Spānija
|
| Date of authorisation/renewal: |
12-Feb-2021
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/16/194/003 |
|
1 |
Stikla pudelīte, 10000 deva |
-
|
|
|
Porcilis PCV M Hyo ID
|
-
|
EU/2/24/319/001
|
Intervet International B.V., Nīderlande
|
QI09AL08
|
pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
emulsion for injection
|
| International name (active substance): |
Porcine circovirus type 2, ORF2 capsid protein
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
30-Aug-2024
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/24/319/001 |
|
1 |
I tipa stikla flakons, 50 deva |
-
|
|
|
Portela 2,5 mg
|
2.5 mg
|
EU/2/25/353/002
|
Zoetis Belgium S.A., Beļģija
|
QN02BG
|
cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Relfovetmab
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Zoetis Belgium S.A., Beļģija
|
| Date of authorisation/renewal: |
27-Oct-2025
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/25/353/002 |
|
2 |
Stikla flakons, 1 ml |
-
|
|
|
Loxicom
|
2.5 mg
|
EU/2/08/090/026
|
Norbrook Laboratories (Ireland) Limited, Īrija
|
QM01AC06
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Meloxicam
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Norbrook Laboratories Limited, Lielbritānija
|
| Date of authorisation/renewal: |
12-Mar-2014
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/08/090/026 |
2,5 mg |
50 |
Blisteris, 10 tablete |
-
|
|
|
RESPIVAC TRT
|
-
|
EU/2/24/314/005
|
Laboratorios Hipra S.A., Spānija
|
QI01AD01
|
chickens
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate for oculonasal suspension/use in drinking water
|
| International name (active substance): |
Turkey rhinotracheitis virus, strain 1062, Live
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
30-May-2024
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/24/314/005 |
|
10 |
Stikla flakons, 1000 devas/flakonā |
-
|
|
|
Equilis Prequenza Te
|
-
|
EU/2/05/057/002
|
Intervet International B.V., Nīderlande
|
QI05AL01
|
horses
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Purified haemagglutinin subunits from equine influenza viruses: A/equine-1/Praque/1/56,A/equine-2/ Newmarket /1/93,A/equine-2/Newmarket /2/93
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Intervet International Booxmer, Nīderlande
|
| Date of authorisation/renewal: |
08-Jul-2005
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
[DOC] EquilisPrequenza (08-Jul-2005)
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/05/057/002 |
|
10 |
Pilnšļirce, 1 deva |
-
|
|
|
BTVPUR
|
-
|
EU/2/10/113/002
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QI04AA02;QI02AA08
|
cattle; sheep
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Bluetongue virus serotype 8 antigen,Bluetongue virus serotype 1 antigen
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
MERIAL, Francija
|
| Date of authorisation/renewal: |
22-Dec-2015
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/10/113/002 |
|
10 |
Polipropilēna pudele, 1000 deva |
-
|
|
|
Increxxa
|
100 mg/ml
|
EU/2/20/258/002
|
Elanco GmbH, Vācija
|
QJ01FA94
|
cattle; pigs; sheep
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Tulathromycin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
FAREVA AMBOISE, Francija
|
| Date of authorisation/renewal: |
16-Sep-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/20/258/002 |
|
1 |
Stikla flakons, 50 ml |
-
|
|
|
PREVEXXION RN
|
0.2 ml
|
EU/2/20/254/003
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QI01AD03
|
chickens
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
concentrate and solvent for suspension for injection
|
| International name (active substance): |
Cell-associated live recombinant Marek’s disease (MD) virus, serotype 1,strain RN1250
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Boehringer Ingelheim Animal Health France SCS , Francija
|
| Date of authorisation/renewal: |
20-Jul-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/20/254/003 |
|
4 |
Stikla ampula, 4000 deva |
-
|
|
|
PRAZIVETIN
|
500 mg/g
|
EU/2/25/340/001
|
VETHELLAS S.A., Grieķija
|
QP52AA01
|
Gilthead
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
premix for medicated feeding stuff
|
| International name (active substance): |
Praziquantel
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
23-Apr-2025
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/25/340/001 |
|
8 |
ZBPE maiss, 2 kg |
-
|
|
|
Clevor
|
30 mg/ml
|
EU/2/17/222/008
|
Orion Corporation, Somija
|
QN04BC04
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
eye drops, solution
|
| International name (active substance): |
Ropinirole hydrochloride
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Orion Corporation, Somija
|
| Date of authorisation/renewal: |
09-Mar-2023
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/17/222/008 |
30 mg/ml |
3 |
ZBPE flakons, 0,6 ml |
-
|
|
|
Leucogen
|
-
|
EU/2/09/096/001
|
Virbac S.A., Francija
|
QI06AA01
|
cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Inactivated feline leukaemia virus
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Virbac S.A., Francija
|
| Date of authorisation/renewal: |
12-Jun-2014
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/09/096/001 |
|
10 |
Stikla flakons, 1 ml |
-
|
|
|
Simparica Trio
|
mg
|
EU/2/19/243/012
|
Zoetis Belgium S.A., Beļģija
|
QP54AB52
|
Dogs > 10-20 kg
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Sarolaner, Moxidectin, Pyrantel embonate
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Corden Pharma GmbH, Vācija
|
| Date of authorisation/renewal: |
17-Sep-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/19/243/012 |
|
6 |
Alumīnija folija blisteris, 1 tablete |
-
|
|